Cutaneous Anaplastic Large-Cell Lymphoma with Dramatic Response to Brentuximab Vedotin

Cutaneous Anaplastic Large-Cell Lymphoma with Dramatic Response to Brentuximab Vedotin

Cutaneous lymphomas account for 5% of non-Hodgkin lymphomas (NHLs). With 75% of skin lymphomas originating from T-cells, CD30+ anaplastic large-cell NHL (ALCL) is the second most common type after mycosis fungoides.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Turkish journal of haematology 2021-01, Vol.38 (1), p.85-86
Hauptverfasser: Şahin, Mustafa, Miskioğlu, Mine, İnanır, Işıl, Akar, Hikmet, Neşe, Nalan, Temiz, Peyker, Aydoğdu, İsmet
Format: Artikel
Sprache:eng
Schlagworte:
Breast cancer
brentuximab
cutaneous anaplastic large cell lymphoma
Letters to the Editor
monotherapy
Tıp
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Cutaneous lymphomas account for 5% of non-Hodgkin lymphomas (NHLs). With 75% of skin lymphomas originating from T-cells, CD30+ anaplastic large-cell NHL (ALCL) is the second most common type after mycosis fungoides.
ISSN:1300-7777
1308-5263
DOI:10.4274/tjh.galenos.2020.2020.0512